The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-(4-(6-((4-(2-(Cyclopentylamino)-4-methylthiazol-5-yl)-pyrimidin-2-yl)amino)pyridin-3-yl)piperazin-1-yl)ethan-1-one ID: ALA4099517
PubChem CID: 135286306
Max Phase: Preclinical
Molecular Formula: C24H30N8OS
Molecular Weight: 478.63
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CC(=O)N1CCN(c2ccc(Nc3nccc(-c4sc(NC5CCCC5)nc4C)n3)nc2)CC1
Standard InChI: InChI=1S/C24H30N8OS/c1-16-22(34-24(27-16)28-18-5-3-4-6-18)20-9-10-25-23(29-20)30-21-8-7-19(15-26-21)32-13-11-31(12-14-32)17(2)33/h7-10,15,18H,3-6,11-14H2,1-2H3,(H,27,28)(H,25,26,29,30)
Standard InChI Key: ONRJNVZFOSHIQI-UHFFFAOYSA-N
Molfile:
RDKit 2D
34 38 0 0 0 0 0 0 0 0999 V2000
38.7816 -3.1834 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.5625 -2.9174 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.2367 -3.3929 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.8972 -2.8986 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
40.6312 -2.1177 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.1066 -1.4434 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
40.7217 -0.7137 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.0858 0.0316 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.4943 0.6044 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.7646 0.2241 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.9052 -0.5962 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.8063 -2.1293 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
40.2484 -4.2177 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.9686 -4.6201 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
40.9803 -5.4450 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.6979 -5.8451 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
42.4212 -5.4482 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.4390 -4.6234 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.1623 -4.2265 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.8676 -4.6543 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.5909 -4.2574 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
44.6087 -3.4327 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
45.3319 -3.0357 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
46.0373 -3.4636 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
46.7604 -3.0667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
46.7351 -2.2421 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
47.4659 -3.4946 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
46.0194 -4.2884 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
45.2962 -4.6854 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.8498 -5.4792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.1265 -5.8761 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
40.2717 -5.8676 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
39.5515 -5.4653 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.5398 -4.6403 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
10 11 1 0
7 11 1 0
5 12 2 0
2 12 1 0
3 13 1 0
13 14 2 0
14 15 1 0
15 16 1 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 1 0
22 23 1 0
23 24 1 0
24 25 1 0
25 26 1 0
25 27 2 0
24 28 1 0
28 29 1 0
21 29 1 0
20 30 1 0
30 31 2 0
17 31 1 0
15 32 2 0
32 33 1 0
33 34 2 0
13 34 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 478.63Molecular Weight (Monoisotopic): 478.2263AlogP: 4.07#Rotatable Bonds: 6Polar Surface Area: 99.17Molecular Species: NEUTRALHBA: 9HBD: 2#RO5 Violations: ┄HBA (Lipinski): 9HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 11.35CX Basic pKa: 3.63CX LogP: 3.06CX LogD: 3.06Aromatic Rings: 3Heavy Atoms: 34QED Weighted: 0.55Np Likeness Score: -1.75
References 1. Tadesse S, Yu M, Mekonnen LB, Lam F, Islam S, Tomusange K, Rahaman MH, Noll B, Basnet SK, Teo T, Albrecht H, Milne R, Wang S.. (2017) Highly Potent, Selective, and Orally Bioavailable 4-Thiazol-N-(pyridin-2-yl)pyrimidin-2-amine Cyclin-Dependent Kinases 4 and 6 Inhibitors as Anticancer Drug Candidates: Design, Synthesis, and Evaluation., 60 (5): [PMID:28156111 ] [10.1021/acs.jmedchem.6b01670 ]